AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease - Wikidata - wikimedia - TriplyDB

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

http://www.wikidata.org/entity/Q33353052

about

An update of biochemical markers of hepatocellular carcinoma Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats.A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease.High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy Activins and follistatins: Emerging roles in liver physiology and cancer A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.Efficacy of Boesenbergia rotunda Treatment against Thioacetamide-Induced Liver Cirrhosis in a Rat Model.Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery.Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma.Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients.Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.Perspectives on using des-γ-carboxyprothrombin (DCP) as a serum biomarker: facilitating early detection of hepatocellular carcinoma in China Combining multiple serum biomarkers in tumor diagnosis: A clinical assessment.Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma.Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.An Easy and Useful Noninvasive Score Based on α-1-acid Glycoprotein and C-Reactive Protein for Diagnosis of Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection.Prognotic impact of serum follistatin in patients with hepatocellular carcinoma.Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.Glypican 3 as a Serum Marker for Hepatoblastoma.Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.Glypican-3-Expressing Hepatocellular Carcinoma in a Non-Cirrhotic Patient with Nonalcoholic Steatohepatitis: Case Report and Literature Review.BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.

P2860

Q26752700-FD1F47F7-9F0D-4BB7-9452-C1952CE31A09 Q26772321-3551D7FD-48DE-4FE6-A783-859681D425F2 Q27003291-4EDAD94D-3ACC-46FE-BA60-A71A021CEA4A Q27023427-EA8DD030-76F4-4944-8BC2-579E39FDAB92 Q27490438-83F500DA-6579-4D08-8695-F395FF733166 Q31112943-75E0FB57-1CF1-4195-B89F-78A595C8B83D Q33490839-46C94D52-70F5-43AD-98AA-42DA14B9C015 Q33509293-8BA26D22-6B34-47BA-BF26-90F39D29483A Q33643368-5CBC9709-2D4E-4B66-AEB3-8A89FC4B836D Q33753952-91466ED7-8445-4666-904A-6F3010DEC85A Q33906226-EEB31E6D-EC33-429E-982D-45C8D621EA9A Q33966440-27FAC19F-F172-4244-850D-3A75A38F7BB2 Q34137427-3D953FE4-2D42-4495-85E5-01316DB3A224 Q34256150-C3032473-0C4F-4C55-BB1C-3530C0B9136B Q34391497-2E25D07F-4524-4EA1-B827-E1357DDE0A3C Q34762279-403E3F29-5310-49E9-ACF2-6F773837ABB5 Q35960878-4ED2C8CB-7F62-4AC8-B66E-1CDBCE254B47 Q36082480-517F097A-7C73-42F8-A8DB-2AA2B359BDC9 Q36228792-2D6188A7-CC49-4C82-9E10-35D31938D10D Q37020982-A60DC55A-C8E3-447B-8687-194DF48E765A Q37178560-0AEF3A50-D84D-4979-B71B-574963FF4D3A Q37206392-0330227F-B971-4542-805F-B44F015D64CD Q37330554-BC318DC3-7ADE-4D5C-8315-D24E9CDFD6F5 Q37343300-E65C2B82-03BB-47E2-A800-59B311445849 Q37584690-CF3A4085-3448-4510-B125-41CDA3B82E93 Q37641050-040513DD-5730-4710-9383-AB0B8C457D47 Q37721997-0F14E809-C11A-4FC4-820C-BED38ACD6384 Q38120063-84787CAD-8141-4903-9551-0AC83A8FAF50 Q38647536-67BDA505-ED1C-4817-922E-5C679C7E5F64 Q38985923-72FA1249-576F-44DC-B523-AAB0C72B5DD2 Q39324590-8AA23123-D0CA-445A-9C51-B1234F8A32D1 Q39463161-0AA7373A-736D-44BD-8AF0-094401C1421C Q39734652-C96D72E6-2635-4DDD-A1EF-B90DA5C26BC0 Q42003901-F997FF6C-74A9-4090-A858-CF731C65E20F Q42278956-40D55227-7EC7-48BB-9B35-914359B35C86 Q43244550-207B266E-6696-4A2E-9EA1-AC2A7C4889A5 Q45465312-9BFD7B3C-F914-4B11-BC02-EF3CBFAD03DA Q46545347-6E9BEA4B-A6D0-428F-B4B1-CB3A6A50F135 Q47237512-E2E6B078-DE1D-4139-B76A-F77994F51A17 Q47920503-C1962397-CE90-4249-A581-3A806BC67E0A

P2860

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

http://www.wikidata.org/entity/Q33353052

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@ast

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@en

type

label

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@ast

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@en

prefLabel

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@ast

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@en

P1433

Q33353052-634E4B07-73A1-48B0-AD47-CB731F965AA2

P1476

Q33353052-42EC1774-30C2-4F98-B71E-B45B8EA18DEF

P2093

Q33353052-0C01395B-74FF-4671-8BD8-0D6D8DA06C40

Q33353052-25EA093C-0263-49B8-877D-A3DF9B24855C

Q33353052-59E8F5DF-A363-4006-B80D-EB6A64908071

Q33353052-90F204ED-6B9E-40C6-B2B6-BD514CD6477B

Q33353052-91D6F291-E3E5-4C64-AAFC-BBDB67DE2403

Q33353052-AC924370-0F0A-4A1F-86A8-BF82B91F5D19

Q33353052-AD539C1E-4CA5-4E41-86E1-D1FA670894E7

Q33353052-DB04482D-D13E-4946-BE93-8FF918139139

P2860

Q33353052-0816CD33-758C-497C-A34F-483423F9996E

Q33353052-1BE25DC4-1A5F-4F67-A54D-BE5123D7E04E

Q33353052-1F516DBD-3552-4A3B-A90B-818941FA5280

Q33353052-271D9A6E-57A9-4D41-BBCF-A92272065BB3

Q33353052-3D64A4B1-5336-4728-A248-A58E90C6CA83

Q33353052-47FD418D-36B7-466D-9EED-F11B97436BBE

Q33353052-4E8C7B39-2A2E-42B9-AD37-B9A4E5A333D6

Q33353052-5722B45F-DAA2-4B60-85C8-8858E0585BFD

Q33353052-57BEC3C3-DB57-4033-A341-6E7C433E467F

Q33353052-5A299EEE-C89B-465C-A7FA-D07BD046A3E6

P2888

Q33353052-1578B0A8-41F3-4D44-B23A-9116CE988E1F

P304

Q33353052-1D9C3BD1-5057-4298-B7CB-FDF0D880AEF8

P31

Q33353052-E7926611-9A5B-4930-A56C-6584DD8E35E6

P356

Q33353052-9045A913-B333-491E-9DBA-165F3543B4F8

P407

Q33353052-75CA4FC3-DADE-4161-91FF-A3E3E8C47327

P478

Q33353052-6422ECD2-5F41-4A87-A762-BB5EC478237D

P50

Q33353052-D0ABE299-34C5-428B-81A7-ADA073943573

Q33353052-F13530BD-0D16-49E1-89B4-2A2BB4F35159

P577

Q33353052-2E70AF40-9B3E-409B-9E60-44059A7AB84F

P5875

Q33353052-FD33D110-529C-44ED-BF55-49DF18A2CEAA

P6179

Q33353052-7750E129-4E22-43C6-9E54-AF820D3A74EB

P698

Q33353052-64D55E58-DFF7-46B9-AEC2-DBEE25742A7A

P921

Q33353052-BEAB45E2-20A6-41FC-88EA-920AFD887C42

P932

Q33353052-2F157091-AF74-4A7D-BD95-39F071CE8E5B

P356

1471-2407-8-200

P1433

P1476

AFP, PIVKAII, GP3, SCCA-1 and ...... alcoholic fatty liver disease

@en

P2093

Christopher Day

http://www.w3.org/2001/XMLSchema#string

Derek Manas

http://www.w3.org/2001/XMLSchema#string

Dipankar Chattopadhyay

http://www.w3.org/2001/XMLSchema#string

Gary Beale

http://www.w3.org/2001/XMLSchema#string

Helen Reeves

http://www.w3.org/2001/XMLSchema#string

Joe Gray

http://www.w3.org/2001/XMLSchema#string

Mark Hudson

http://www.w3.org/2001/XMLSchema#string

Stephen Stewart

http://www.w3.org/2001/XMLSchema#string

P2860

Squamous cell carcinoma antigen is a new member of the serine protease inhibitors

Deregulation of the activin/follistatin system in hepatocarcinogenesis

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Primary liver cancer: worldwide incidence and trends

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Estimating the world cancer burden: Globocan 2000.

P2888

1471-2407-8-200

P304

200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-200

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Giannelli

Paolo Trerotoli

P577

2008-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51412582

http://www.w3.org/2001/XMLSchema#string

P6179

1040673953

http://www.w3.org/2001/XMLSchema#string

P698

18638391

http://www.w3.org/2001/XMLSchema#string

P921

P932

2488355

http://www.w3.org/2001/XMLSchema#string